The i-gel is an innovative second-generation supraglottic airway with a soft, gel-like, non-inflatable cuff. The i-gel is designed to create a non-inflatable anatomical seal of the pharyngeal, laryngeal and peri-laryngeal structures.
We are living in a time of huge technological change. This fourth industrial revolution is characterised by a fusion of technologies that is blurring the lines between the physical, digital, and biological spheres. It is also disrupting nearly every ...
In today's world, the call for controlled manufacturing is standard across a wide range of industries. Processing and cleaning controls continue to grow ever more stringent in biotechnology and pharmaceutical production - at the same time engineers i...
The biopsy devices market has benefitted from being suitable for the diagnosis of a variety of cancer indications, and will grow from $506.4m in 2013 to $602.4m in 2019, at a global compound annual growth rate (CAGR) of 2.93%.
Controlling liquid infectious waste continues to present multiple challenges. As regulations tighten and operating costs rise, it's important to find a safe, cost-effective solution that's affordable and provides minimal environmental impact.
This white paper identifies current issues with the Health Identifier (HI) service that may impact software vendors, Medical Software Industry Association (MSIA) members and associated software products.
The majority of pre-hospital intubations in the state of Maine are in patients suffering from out-of-hospital cardiac arrest (approximately 83%), and certainly, airway management is essential for these patients.
The aim of the white paper is to increase US healthcare innovation and assist Israeli healthcare companies by empowering them to do business in the US market, both independently and through increased partnerships with American companies.
This white paper provides a literature review of incident disclosure research, policy and legal reform documents published since 2008. The last four years have seen an explosion of policy and literature on all aspects of incident disclosure.
This white paper has been developed for outpatient oncology facilities to serve as a model for a basic infection control and prevention plan, containing policies and procedures tailored to meet minimal expectations of patient protections, as describe...